175 related articles for article (PubMed ID: 11933219)
1. Receptor-mediated delivery of an antisense gene to human brain cancer cells.
Zhang Y; Jeong Lee H; Boado RJ; Pardridge WM
J Gene Med; 2002; 4(2):183-94. PubMed ID: 11933219
[TBL] [Abstract][Full Text] [Related]
2. Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer.
Zhang Y; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
Mol Vis; 2003 Oct; 9():465-72. PubMed ID: 14551536
[TBL] [Abstract][Full Text] [Related]
3. Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer.
Zhang Y; Zhang YF; Bryant J; Charles A; Boado RJ; Pardridge WM
Clin Cancer Res; 2004 Jun; 10(11):3667-77. PubMed ID: 15173073
[TBL] [Abstract][Full Text] [Related]
4. In vivo knockdown of gene expression in brain cancer with intravenous RNAi in adult rats.
Zhang Y; Boado RJ; Pardridge WM
J Gene Med; 2003 Dec; 5(12):1039-45. PubMed ID: 14661179
[TBL] [Abstract][Full Text] [Related]
5. Antisense gene therapy of brain cancer with an artificial virus gene delivery system.
Zhang Y; Zhu C; Pardridge WM
Mol Ther; 2002 Jul; 6(1):67-72. PubMed ID: 12095305
[TBL] [Abstract][Full Text] [Related]
6. Marked enhancement in gene expression by targeting the human insulin receptor.
Zhang Y; Boado RJ; Pardridge WM
J Gene Med; 2003 Feb; 5(2):157-63. PubMed ID: 12539153
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive gene targeting to the fetal brain after intravenous administration and transplacental transfer of plasmid DNA using PEGylated immunoliposomes.
Cornford EM; Hyman S; Cornford ME; Chytrova G; Rhee J; Suzuki T; Yamagata T; Yamakawa K; Penichet ML; Pardridge WM
J Drug Target; 2016; 24(1):58-67. PubMed ID: 26133964
[TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes.
Shi N; Boado RJ; Pardridge WM
Pharm Res; 2001 Aug; 18(8):1091-5. PubMed ID: 11587478
[TBL] [Abstract][Full Text] [Related]
9. Intravenous, non-viral RNAi gene therapy of brain cancer.
Pardridge WM
Expert Opin Biol Ther; 2004 Jul; 4(7):1103-13. PubMed ID: 15268677
[TBL] [Abstract][Full Text] [Related]
10. Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter.
Zhang Y; Schlachetzki F; Zhang YF; Boado RJ; Pardridge WM
Hum Gene Ther; 2004 Apr; 15(4):339-50. PubMed ID: 15053859
[TBL] [Abstract][Full Text] [Related]
11. Global non-viral gene transfer to the primate brain following intravenous administration.
Zhang Y; Schlachetzki F; Pardridge WM
Mol Ther; 2003 Jan; 7(1):11-8. PubMed ID: 12573613
[TBL] [Abstract][Full Text] [Related]
12. Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues.
Takakuwa K; Fujita K; Kikuchi A; Sugaya S; Yahata T; Aida H; Kurabayashi T; Hasegawa I; Tanaka K
Jpn J Cancer Res; 1997 Feb; 88(2):166-75. PubMed ID: 9119745
[TBL] [Abstract][Full Text] [Related]
13. RNA interference and nonviral targeted gene therapy of experimental brain cancer.
Boado RJ
NeuroRx; 2005 Jan; 2(1):139-50. PubMed ID: 15717065
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter.
He Y; Zeng Q; Drenning SD; Melhem MF; Tweardy DJ; Huang L; Grandis JR
J Natl Cancer Inst; 1998 Jul; 90(14):1080-7. PubMed ID: 9672256
[TBL] [Abstract][Full Text] [Related]
15. Brain-specific expression of an exogenous gene after i.v. administration.
Shi N; Zhang Y; Zhu C; Boado RJ; Pardridge WM
Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12754-9. PubMed ID: 11592987
[TBL] [Abstract][Full Text] [Related]
16. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.
Grill J; Van Beusechem VW; Van Der Valk P; Dirven CM; Leonhart A; Pherai DS; Haisma HJ; Pinedo HM; Curiel DT; Gerritsen WR
Clin Cancer Res; 2001 Mar; 7(3):641-50. PubMed ID: 11297260
[TBL] [Abstract][Full Text] [Related]
17. Messenger RNA expression profiling of genes involved in epidermal growth factor receptor signalling in human cancer cells treated with scanning array-designed antisense oligonucleotides.
Petch AK; Sohail M; Hughes MD; Benter I; Darling J; Southern EM; Akhtar S
Biochem Pharmacol; 2003 Sep; 66(5):819-30. PubMed ID: 12948863
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of transfection efficiency between liposomes, immunoliposomes and brain-specific immunoliposomes.
Zhao H; Li GL; Wang RZ; Li SF; Wei JJ; Feng M; Zhao YJ; Ma WB; Yang Y; Li YN; Kong YG
J Int Med Res; 2010; 38(3):957-66. PubMed ID: 20819432
[TBL] [Abstract][Full Text] [Related]
19. A study on the relationship between antisense EGFR cDNA fragments and nuclear matrix proteins in glioblastoma cells.
Wang ZH; Yam GH; Tian XX; Ng HK; Chew-Cheng SB; Ding MX; Chew EC
Int J Mol Med; 1998 Oct; 2(4):417-21. PubMed ID: 9857227
[TBL] [Abstract][Full Text] [Related]
20. Preparation of Trojan horse liposomes (THLs) for gene transfer across the blood-brain barrier.
Pardridge WM
Cold Spring Harb Protoc; 2010 Apr; 2010(4):pdb.prot5407. PubMed ID: 20360361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
